Barcutean L - Search Results

1

Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia.

Motataianu A, Barcutean L, Balasa R. Motataianu A, et al. Among authors: barcutean l. Amyotroph Lateral Scler Frontotemporal Degener. 2020 May;21(3-4):159-166. doi: 10.1080/21678421.2019.1708949. Epub 2020 Jan 6. Amyotroph Lateral Scler Frontotemporal Degener. 2020. PMID: 31903792 Review.

2

Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action.

Balasa RI, Simu M, Voidazan S, Barcutean LI, Bajko Z, Hutanu A, Simu I, Maier S. Balasa RI, et al. CNS Neurol Disord Drug Targets. 2017;16(9):1018-1026. doi: 10.2174/1871527316666170807130632. CNS Neurol Disord Drug Targets. 2017. PMID: 28782487

3

Malignant Middle Cerebral Artery Infarction Secondary to Traumatic Bilateral Internal Carotid Artery Dissection. A Case Report.

Bajkó Z, Bălaşa R, Moţăţăianu A, Bărcuţean L, Stoian A, Stirbu N, Maier S. Bajkó Z, et al. Among authors: barcutean l. J Crit Care Med (Targu Mures). 2016 Aug 10;2(3):135-141. doi: 10.1515/jccm-2016-0021. eCollection 2016 Jul. J Crit Care Med (Targu Mures). 2016. PMID: 29967852 Free PMC article.

4

Clinical and Serological Biomarkers of Treatment's Response in Multiple Sclerosis Patients Treated Continuously with Interferonβ-1b for More than a Decade.

Bărcuţean LI, Romaniuc A, Maier S, Bajko Z, Moţăţăianu A, Adina H, Simu I, Andone S, Bălaşa R. Bărcuţean LI, et al. CNS Neurol Disord Drug Targets. 2018;17(10):780-792. doi: 10.2174/1871527317666180917095256. CNS Neurol Disord Drug Targets. 2018. PMID: 30221605

5

The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.

Balasa R, Barcutean L, Balasa A, Motataianu A, Roman-Filip C, Manu D. Balasa R, et al. Among authors: barcutean l. Hum Immunol. 2020 May;81(5):237-243. doi: 10.1016/j.humimm.2020.02.009. Epub 2020 Feb 28. Hum Immunol. 2020. PMID: 32122685 Review.

6

Malignant melanoma - the most severe skin cancer and neurological pathology.

Moţăţăianu AI, Maier MS, Chinezu L, Bărcuţean LI, Voidăzan TS, Bajkó Z, Bălaşa AF. Moţăţăianu AI, et al. Among authors: barcutean li. Rom J Morphol Embryol. 2019;60(4):1207-1214. Rom J Morphol Embryol. 2019. PMID: 32239096 Free article.

7

The Main Determinants for Suicidal Ideation in a Romanian Cohort of Multiple Sclerosis Patients.

Romaniuc A, Bălaşa R, Ştirbu N, Maier S, Andone S, Bajko Z, Bărcuţean L, Voidăzan S, Moţăţăianu A. Romaniuc A, et al. Among authors: barcutean l. Behav Neurol. 2020 Jan 21;2020:2594702. doi: 10.1155/2020/2594702. eCollection 2020. Behav Neurol. 2020. PMID: 32399081 Free PMC article.

8

Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab.

Maier S, Simu M, Hutanu A, Barcutean L, Voidazan S, Bajko Z, Motataianu A, Lata I, Balasa R. Maier S, et al. Among authors: barcutean l. Brain Sci. 2020 Oct 30;10(11):802. doi: 10.3390/brainsci10110802. Brain Sci. 2020. PMID: 33143271 Free PMC article.

9

Postpartum Cerebral Venous Thrombosis-A Single-Center Experience.

Bajko Z, Motataianu A, Stoian A, Barcutean L, Andone S, Maier S, Drăghici IA, Balasa R. Bajko Z, et al. Among authors: barcutean l. Brain Sci. 2021 Mar 4;11(3):327. doi: 10.3390/brainsci11030327. Brain Sci. 2021. PMID: 33806706 Free PMC article.

10

Gender Differences in Risk Factor Profile and Clinical Characteristics in 89 Consecutive Cases of Cerebral Venous Thrombosis.

Bajko Z, Motataianu A, Stoian A, Barcutean L, Andone S, Maier S, Drăghici IA, Cioban A, Balasa R. Bajko Z, et al. Among authors: barcutean l. J Clin Med. 2021 Mar 30;10(7):1382. doi: 10.3390/jcm10071382. J Clin Med. 2021. PMID: 33808141 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page